top
Search terms
Results 1 - 10 of 12 - ordered by :
Pages: 1 2
Ehjournal

Abstract Aims To describe the incidence of dyspnoea and its associations with demographic characteristics and clinical outcomes in patients with acute coronary syndromes (ACS) treated with ticagrelor ...

European Heart Journal, Storey, Robert F., Becker, Richard C., Harrington, Robert A., Husted, Steen, James, Stefan K., Cools, Frank, Steg, Philippe Gabriel, Khurmi, Nardev S., Emanuelsson, HÃ¥kan, ...

Date : 01/12/2011 Item size : 219428 bytes
Ehjournal

Introduction Oral anticoagulation is recommended for the prevention of thromboembolic events in patients with atrial fibrillation (AF) at risk for stroke.13 Oral anticoagulants have been shown to be ...

European Heart Journal, Alexander, John H., Lopes, Renato D., Thomas, Laine, Alings, Marco, Atar, Dan, Aylward, Philip, Goto, Shinya, Hanna, Michael, Huber, Kurt, Husted, Steen, Lewis, Basil S., ...

Date : 21/01/2014 Item size : 298281 bytes
Ehjournal

Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study Growth differentiation factor-15 ...

European Heart Journal, Hagström, Emil, James, Stefan K., Bertilsson, Maria, Becker, Richard C., Himmelmann, Anders, Husted, Steen, Katus, Hugo A., Steg, Philippe Gabriel, Storey, Robert F., ...

Date : 21/04/2016 Item size : 270625 bytes
Ehjournal

In NSTE-ACS patients, the primary endpoint was reduced with ticagrelor vs. clopidogrel [10.0 vs. 12.3%; hazard ratio (HR) 0.83; 95% confidence interval (CI) = 0.740.93], as was myocardial infarction ...

European Heart Journal, Lindholm, Daniel, Varenhorst, Christoph, Cannon, Christopher P, Harrington, Robert A, Himmelmann, Anders, Maya, Juan, Husted, Steen, Steg, Philippe Gabriel, Cornel, Jan H, ...

Date : 14/08/2014
Ehjournal

In NSTE-ACS patients, the primary endpoint was reduced with ticagrelor vs. clopidogrel [10.0 vs. 12.3%; hazard ratio (HR) 0.83; 95% confidence interval (CI) = 0.740.93], as was myocardial infarction ...

European Heart Journal, Lindholm, Daniel, Varenhorst, Christoph, Cannon, Christopher P, Harrington, Robert A, Himmelmann, Anders, Maya, Juan, Husted, Steen, Steg, Philippe Gabriel, Cornel, Jan H, ...

Date : 14/08/2014 Item size : 311147 bytes
Ehjournal

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromesThe Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of ...

European Heart Journal, Bassand, Jean-Pierre, Hamm, Christian W., Ardissino, Diego, Boersma, Eric, Budaj, Andrzej, Fernández-Avilés, Francisco, Fox, Keith A.A., Hasdai, David, Ohman, E. Magnus, ...

Date : 01/07/2007 Item size : 2214915 bytes
Ehjournal

Abstract Aims To describe the incidence of dyspnoea and its associations with demographic characteristics and clinical outcomes in patients with acute coronary syndromes (ACS) treated with ticagrelor ...

European Heart Journal, Storey, Robert F., Becker, Richard C., Harrington, Robert A., Husted, Steen, James, Stefan K., Cools, Frank, Steg, Philippe Gabriel, Khurmi, Nardev S., Emanuelsson, HÃ¥kan, ...

Date : 01/12/2011
Ehjournal

Introduction Oral anticoagulation is recommended for the prevention of thromboembolic events in patients with atrial fibrillation (AF) at risk for stroke.13 Oral anticoagulants have been shown to be ...

European Heart Journal, Alexander, John H., Lopes, Renato D., Thomas, Laine, Alings, Marco, Atar, Dan, Aylward, Philip, Goto, Shinya, Hanna, Michael, Huber, Kurt, Husted, Steen, Lewis, Basil S., ...

Date : 21/01/2014
Ehjournal

Methods and results In 15828 patients from the STABILITY trial (darapladib vs. placebo in patients with established coronary heart disease), BP variability was assessed by the standard deviation (SD) ...

European Heart Journal, Vidal-Petiot, Emmanuelle, Stebbins, Amanda, Chiswell, Karen, Ardissino, Diego, Aylward, Philip E., Cannon, Christopher P., Ramos Corrales, Marco A., Held, Claes, ...

Date : 01/10/2017
Ehjournal

Methods and results In 15828 patients from the STABILITY trial (darapladib vs. placebo in patients with established coronary heart disease), BP variability was assessed by the standard deviation (SD) ...

European Heart Journal, Vidal-Petiot, Emmanuelle, Stebbins, Amanda, Chiswell, Karen, Ardissino, Diego, Aylward, Philip E., Cannon, Christopher P., Ramos Corrales, Marco A., Held, Claes, ...

Date : 01/10/2017